Follow the people · Insider
Amy McBride Wendell
Amy McBride Wendell files insider transactions with the SEC as a director of Axogen (AXGN). We hold 3 disclosed purchases and sales filed since 5 July 2007, 1 of them in the last 90 days.
- Files forAXGN
- Disclosed buys and sells3 in all, 1 in the last 90 days
- Last disclosure12 August 2026
Positions held
6 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 16 September 2016 — 11 August 2026Director · Axogen (AXGN)57 Form 4 lines · source: SEC Form 4
- Filed 13 May 2024 — 15 May 2026Director · Solventum (SOLV)14 Form 4 lines · source: SEC Form 4
- Filed 18 February 2019 — 5 May 2026Director · Baxter International (BAX)13 Form 4 lines · source: SEC Form 4
- Filed 14 December 2016 — 7 April 2026Director · Hologic (HOLX)34 Form 4 lines · source: SEC Form 4
- Filed 24 May 2016 — 14 September 2017Director · Ekso Bionics Holdings (EKSO)3 Form 4 lines · source: SEC Form 4
- Filed 2 July 2007 — 26 January 2015Senior Vice President · Covidien (COV)113 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 13,353 shares of AxogenSEC Form 412 August 2026Common Stock · traded 11 August 2026 · filed 12 August 2026
- ▼ sold on the open market 13,353 shares of AxogenSEC Form 412 August 2026Common Stock · traded 11 August 2026 · filed 12 August 2026
- exercised options over 13,353 shares of Axogen (a derivative holding)SEC Form 412 August 2026Employee Stock Option (right to purchase) · traded 11 August 2026 · filed 12 August 2026
- was granted 4,392 shares of Axogen (a derivative holding)SEC Form 426 June 2026Restricted Stock Units · traded 24 June 2026 · filed 26 June 2026
- exercised options over 14,150 shares of AxogenSEC Form 423 June 2026Common Stock · traded 19 June 2026 · filed 23 June 2026
- exercised options over 14,150 shares of Axogen (a derivative holding)SEC Form 423 June 2026Restricted Stock Units · traded 19 June 2026 · filed 23 June 2026
- was granted 3,300 shares of Solventum (a derivative holding)SEC Form 418 May 2026Restricted Stock Units · traded 15 May 2026 · filed 18 May 2026
- exercised options over 1,647 shares of AxogenSEC Form 412 May 2026Common Stock · traded 8 May 2026 · filed 12 May 2026
- ▼ sold on the open market 1,647 shares of AxogenSEC Form 412 May 2026Common Stock · traded 8 May 2026 · filed 12 May 2026
- exercised options over 1,647 shares of Axogen (a derivative holding)SEC Form 412 May 2026Employee Stock Option (right to purchase) · traded 8 May 2026 · filed 12 May 2026
- was granted 12,836 shares of Baxter InternationalSEC Form 47 May 2026Common Stock, $1 par value · traded 5 May 2026 · filed 7 May 2026
- exercised options over 3,403 shares of SolventumSEC Form 41 May 2026Common Stock · traded 30 April 2026 · filed 1 May 2026
- exercised options over 3,403 shares of Solventum (a derivative holding)SEC Form 41 May 2026Restricted Stock Units · traded 30 April 2026 · filed 1 May 2026
- returned to the issuer 25,784 shares of HologicSEC Form 49 April 2026Common Stock · traded 7 April 2026 · filed 9 April 2026
- returned to the issuer 4,536 shares of Hologic (a derivative holding)SEC Form 49 April 2026Non-qualified Stock Option (Right to Buy) · traded 7 April 2026 · filed 9 April 2026
- returned to the issuer 5,535 shares of Hologic (a derivative holding)SEC Form 49 April 2026Non-qualified Stock Option (Right to Buy) · traded 7 April 2026 · filed 9 April 2026
- returned to the issuer 1,500 shares of Hologic (a derivative holding)SEC Form 49 April 2026Non-qualified Stock Option (Right to Buy) · traded 7 April 2026 · filed 9 April 2026
- returned to the issuer 6,816 shares of Hologic (a derivative holding)SEC Form 49 April 2026Non-qualified Stock Option (Right to Buy) · traded 7 April 2026 · filed 9 April 2026
- returned to the issuer 7,551 shares of Hologic (a derivative holding)SEC Form 49 April 2026Non-qualified Stock Option (Right to Buy) · traded 7 April 2026 · filed 9 April 2026
- returned to the issuer 6,523 shares of Hologic (a derivative holding)SEC Form 49 April 2026Non-qualified Stock Option (Right to Buy) · traded 7 April 2026 · filed 9 April 2026
- returned to the issuer 7,322 shares of Hologic (a derivative holding)SEC Form 49 April 2026Non-qualified Stock Option (Right to Buy) · traded 7 April 2026 · filed 9 April 2026
- returned to the issuer 5,055 shares of Hologic (a derivative holding)SEC Form 49 April 2026Non-qualified Stock Option (Right to Buy) · traded 7 April 2026 · filed 9 April 2026
- returned to the issuer 5,293 shares of Hologic (a derivative holding)SEC Form 49 April 2026Non-qualified Stock Option (Right to Buy) · traded 7 April 2026 · filed 9 April 2026
- returned to the issuer 4,210 shares of Hologic (a derivative holding)SEC Form 49 April 2026Non-qualified Stock Option (Right to Buy) · traded 7 April 2026 · filed 9 April 2026
- exercised options over 1,980 shares of SolventumSEC Form 430 March 2026Common Stock · traded 27 March 2026 · filed 30 March 2026
- exercised options over 1,980 shares of Solventum (a derivative holding)SEC Form 430 March 2026Restricted Stock Units · traded 27 March 2026 · filed 30 March 2026
- exercised options over 1,980 shares of Solventum (a derivative holding)SEC Form 430 March 2026Restricted Stock Units · traded 27 March 2026 · filed 30 March 2026
- exercised options over 1,980 shares of SolventumSEC Form 430 March 2026Common Stock · traded 27 March 2026 · filed 30 March 2026
- ▲ bought on the open market 1,475 shares of SolventumSEC Form 411 March 2026Common Stock · traded 10 March 2026 · filed 11 March 2026
- ▲ bought on the open market 1,475 shares of SolventumSEC Form 411 March 2026Common Stock · traded 10 March 2026 · filed 11 March 2026
- was granted 3,190 shares of HologicSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- was granted 3,190 shares of HologicSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- exercised options over 5,000 shares of Axogen (a derivative holding)SEC Form 417 December 2025Stock Option (right to purchase) · traded 16 December 2025 · filed 17 December 2025
- exercised options over 20,436 shares of Axogen (a derivative holding)SEC Form 417 December 2025Stock Option (right to purchase) · traded 16 December 2025 · filed 17 December 2025
- exercised options over 18,248 shares of Axogen (a derivative holding)SEC Form 417 December 2025Stock Option (right to purchase) · traded 16 December 2025 · filed 17 December 2025
- exercised options over 5,000 shares of AxogenSEC Form 417 December 2025Common Stock · traded 16 December 2025 · filed 17 December 2025
- exercised options over 20,436 shares of AxogenSEC Form 417 December 2025Common Stock · traded 16 December 2025 · filed 17 December 2025
- exercised options over 18,248 shares of AxogenSEC Form 417 December 2025Common Stock · traded 16 December 2025 · filed 17 December 2025
- ▼ sold on the open market 5,000 shares of AxogenSEC Form 417 December 2025Common Stock · traded 16 December 2025 · filed 17 December 2025
- ▼ sold on the open market 20,436 shares of AxogenSEC Form 417 December 2025Common Stock · traded 16 December 2025 · filed 17 December 2025
- ▼ sold on the open market 18,248 shares of AxogenSEC Form 417 December 2025Common Stock · traded 16 December 2025 · filed 17 December 2025
- was granted 14,150 shares of Axogen (a derivative holding)SEC Form 420 June 2025Restricted Stock Units · traded 19 June 2025 · filed 20 June 2025
- ▼ sold on the open market 4,073 shares of AxogenSEC Form 411 June 2025Common Stock · traded 9 June 2025 · filed 11 June 2025
- exercised options over 3,564 shares of Solventum (a derivative holding)SEC Form 415 May 2025Restricted Stock Units · traded 13 May 2025 · filed 15 May 2025
- exercised options over 3,564 shares of SolventumSEC Form 415 May 2025Common Stock · traded 13 May 2025 · filed 15 May 2025
- was granted 7,183 shares of Baxter InternationalSEC Form 48 May 2025Common Stock, $1 par value · traded 6 May 2025 · filed 8 May 2025
- was granted 3,403 shares of Solventum (a derivative holding)SEC Form 42 May 2025Restricted Stock Units · traded 30 April 2025 · filed 2 May 2025
- ▼ sold on the open market 5,000 shares of AxogenSEC Form 45 March 2025Common Stock · traded 3 March 2025 · filed 5 March 2025
- was granted 5,535 shares of Hologic (a derivative holding)SEC Form 428 February 2025Non-qualified Stock Option (Right to Buy) · traded 26 February 2025 · filed 28 February 2025
- was granted 1,864 shares of HologicSEC Form 428 February 2025Common Stock · traded 26 February 2025 · filed 28 February 2025
- exercised options over 11,904 shares of Axogen (a derivative holding)SEC Form 44 September 2024Restricted Stock Units · traded 1 September 2024 · filed 4 September 2024
- exercised options over 11,904 shares of AxogenSEC Form 44 September 2024Common Stock · traded 1 September 2024 · filed 4 September 2024
- was granted 18,248 shares of Axogen (a derivative holding)SEC Form 410 June 2024Stock Option (right to purchase) · traded 6 June 2024 · filed 10 June 2024
- was granted 10,653 shares of AxogenSEC Form 410 June 2024Common Stock · traded 6 June 2024 · filed 10 June 2024
- was granted 3,564 shares of Solventum (a derivative holding)SEC Form 415 May 2024Restricted Stock Units · traded 13 May 2024 · filed 15 May 2024
- was granted 1,980 shares of Solventum (a derivative holding)SEC Form 415 May 2024Restricted Stock Units · traded 13 May 2024 · filed 15 May 2024
- was granted 5,952 shares of Baxter InternationalSEC Form 49 May 2024Common Stock, $1 par value · traded 7 May 2024 · filed 9 May 2024
- was granted 4,536 shares of Hologic (a derivative holding)SEC Form 411 March 2024Non-qualified Stock Option (Right to Buy) · traded 7 March 2024 · filed 11 March 2024
- was granted 1,572 shares of HologicSEC Form 411 March 2024Common Stock · traded 7 March 2024 · filed 11 March 2024
- ▲ bought on the open market 10,000 shares of AxogenSEC Form 48 September 2023Common Stock · traded 6 September 2023 · filed 8 September 2023
- was granted 20,436 shares of Axogen (a derivative holding)SEC Form 47 September 2023Stock Option (right to purchase) · traded 1 September 2023 · filed 7 September 2023
- was granted 11,904 shares of Axogen (a derivative holding)SEC Form 47 September 2023Restricted Stock Units · traded 1 September 2023 · filed 7 September 2023
- exercised options over 6,459 shares of Axogen (a derivative holding)SEC Form 45 June 2023Restricted Stock Units · traded 1 June 2023 · filed 5 June 2023
- exercised options over 6,459 shares of AxogenSEC Form 45 June 2023Common Stock · traded 1 June 2023 · filed 5 June 2023
- exercised options over 25,000 shares of Axogen (a derivative holding)SEC Form 416 May 2023Stock Option (right to buy) · traded 12 May 2023 · filed 16 May 2023
- exercised options over 3,750 shares of Axogen (a derivative holding)SEC Form 416 May 2023Stock Option (right to buy) · traded 12 May 2023 · filed 16 May 2023
- exercised options over 25,000 shares of AxogenSEC Form 416 May 2023Common Stock · traded 12 May 2023 · filed 16 May 2023
- exercised options over 3,750 shares of AxogenSEC Form 416 May 2023Common Stock · traded 12 May 2023 · filed 16 May 2023
- was granted 4,573 shares of Baxter InternationalSEC Form 44 May 2023Common Stock, $1 par value · traded 2 May 2023 · filed 4 May 2023
- was granted 4,210 shares of Hologic (a derivative holding)SEC Form 413 March 2023Non-qualified Stock Option (Right to Buy) · traded 9 March 2023 · filed 13 March 2023
- was granted 1,465 shares of HologicSEC Form 413 March 2023Common Stock · traded 9 March 2023 · filed 13 March 2023
- exercised options over 3,036 shares of Axogen (a derivative holding)SEC Form 43 June 2022Restricted Stock Units · traded 1 June 2022 · filed 3 June 2022
- was granted 11,811 shares of Axogen (a derivative holding)SEC Form 43 June 2022Stock Option (right to purchase) · traded 1 June 2022 · filed 3 June 2022
- was granted 6,459 shares of Axogen (a derivative holding)SEC Form 43 June 2022Restricted Stock Units · traded 1 June 2022 · filed 3 June 2022
- exercised options over 3,036 shares of AxogenSEC Form 43 June 2022Common Stock · traded 1 June 2022 · filed 3 June 2022
- was granted 2,706 shares of Baxter InternationalSEC Form 45 May 2022Common Stock, $1 par value · traded 3 May 2022 · filed 5 May 2022
- was granted 5,293 shares of Hologic (a derivative holding)SEC Form 414 March 2022Non-qualified Stock Option (Right to Buy) · traded 10 March 2022 · filed 14 March 2022
- was granted 1,565 shares of HologicSEC Form 414 March 2022Common Stock · traded 10 March 2022 · filed 14 March 2022
- exercised options over 6,173 shares of Axogen (a derivative holding)SEC Form 43 June 2021Restricted Stock Units · traded 1 June 2021 · filed 3 June 2021
- was granted 6,030 shares of Axogen (a derivative holding)SEC Form 43 June 2021Stock Option (right to purchase) · traded 1 June 2021 · filed 3 June 2021
- was granted 3,036 shares of Axogen (a derivative holding)SEC Form 43 June 2021Restricted Stock Units · traded 1 June 2021 · filed 3 June 2021
- exercised options over 6,173 shares of AxogenSEC Form 43 June 2021Common Stock · traded 1 June 2021 · filed 3 June 2021
- was granted 1,116 shares of Baxter InternationalSEC Form 46 May 2021Common Stock, $1 par value · traded 4 May 2021 · filed 6 May 2021
- was granted 5,685 shares of Baxter International (a derivative holding)SEC Form 46 May 2021Stock Option (Right to Buy) · traded 4 May 2021 · filed 6 May 2021
- was granted 1,478 shares of HologicSEC Form 415 March 2021Common Stock · traded 11 March 2021 · filed 15 March 2021
- was granted 5,055 shares of Hologic (a derivative holding)SEC Form 415 March 2021Non-qualified Stock Option (Right to Buy) · traded 11 March 2021 · filed 15 March 2021
- was granted 2,591 shares of AxogenSEC Form 48 September 2020Common Stock · traded 3 September 2020 · filed 8 September 2020
- was granted 12,605 shares of Axogen (a derivative holding)SEC Form 412 June 2020Stock Option (right to purchase) · traded 1 June 2020 · filed 12 June 2020
- was granted 6,173 shares of Axogen (a derivative holding)SEC Form 412 June 2020Restricted Stock Units · traded 1 June 2020 · filed 12 June 2020
- was granted 16,807 shares of Axogen (a derivative holding)SEC Form 43 June 2020Stock Option (right to purchase) · traded 1 June 2020 · filed 3 June 2020
- was granted 4,115 shares of Axogen (a derivative holding)SEC Form 43 June 2020Restricted Stock Units · traded 1 June 2020 · filed 3 June 2020
- was granted 5,293 shares of Baxter International (a derivative holding)SEC Form 47 May 2020Stock Option (Right to Buy) · traded 5 May 2020 · filed 7 May 2020
- was granted 1,099 shares of Baxter InternationalSEC Form 47 May 2020Common Stock, $1 par value · traded 5 May 2020 · filed 7 May 2020
- was granted 1,500 shares of Baxter InternationalSEC Form 419 March 2020Common Stock, $1 par value · traded 19 March 2020 · filed 19 March 2020
- was granted 7,322 shares of Hologic (a derivative holding)SEC Form 49 March 2020Non-qualified Stock Option (Right to Buy) · traded 5 March 2020 · filed 9 March 2020
- was granted 2,217 shares of HologicSEC Form 49 March 2020Common Stock · traded 5 March 2020 · filed 9 March 2020
- was granted 10,710 shares of Axogen (a derivative holding)SEC Form 44 September 2019Stock Option (right to purchase) · traded 3 September 2019 · filed 4 September 2019
- was granted 2,591 shares of Axogen (a derivative holding)SEC Form 44 September 2019Restricted Stock Units · traded 3 September 2019 · filed 4 September 2019
- ▲ bought on the open market 5,000 shares of AxogenSEC Form 414 June 2019Common Stock · traded 13 June 2019 · filed 14 June 2019
- was granted 6,138 shares of Baxter International (a derivative holding)SEC Form 49 May 2019Stock Option (Right to Buy) · traded 7 May 2019 · filed 9 May 2019
- was granted 1,206 shares of Baxter InternationalSEC Form 49 May 2019Common Stock, $1 par value · traded 7 May 2019 · filed 9 May 2019
- was granted 6,523 shares of Hologic (a derivative holding)SEC Form 412 March 2019Non-qualified Stock Option (Right to Buy) · traded 7 March 2019 · filed 12 March 2019
- was granted 2,136 shares of HologicSEC Form 412 March 2019Common Stock · traded 7 March 2019 · filed 12 March 2019
- was granted 444 shares of Baxter InternationalSEC Form 420 February 2019Common Stock, $1 par value · traded 18 February 2019 · filed 20 February 2019
- ▲ bought on the open market 5,000 shares of AxoGenSEC Form 416 August 2018Common Stock · traded 14 August 2018 · filed 16 August 2018
- was granted 4,780 shares of AxoGen (a derivative holding)SEC Form 45 June 2018Stock Option (right to purchase) · traded 1 June 2018 · filed 5 June 2018
- was granted 7,551 shares of Hologic (a derivative holding)SEC Form 416 March 2018Non-qualified Stock Option (Right to Buy) · traded 14 March 2018 · filed 16 March 2018
- was granted 2,406 shares of HologicSEC Form 416 March 2018Common Stock · traded 14 March 2018 · filed 16 March 2018
- ▲ bought on the open market 5,200 shares of HologicSEC Form 416 March 2018Common Stock · traded 14 March 2018 · filed 16 March 2018
- ▲ bought on the open market 16,264 shares of Ekso Bionics HoldingsSEC Form 415 September 2017Common Stock · traded 14 September 2017 · filed 15 September 2017
- was granted 25,000 shares of Ekso Bionics Holdings (a derivative holding)SEC Form 47 July 2017Stock Option (right to buy) · traded 5 July 2017 · filed 7 July 2017
- was granted 15,000 shares of AxoGen (a derivative holding)SEC Form 45 June 2017Stock Option (right to purchase) · traded 1 June 2017 · filed 5 June 2017
- was granted 2,206 shares of HologicSEC Form 49 March 2017Common Stock · traded 8 March 2017 · filed 9 March 2017
- was granted 6,816 shares of Hologic (a derivative holding)SEC Form 49 March 2017Non-qualified Stock Option (Right to Buy) · traded 8 March 2017 · filed 9 March 2017
- was granted 5,000 shares of AxoGen (a derivative holding)SEC Form 43 January 2017Stock Option (right to purchase) · traded 29 December 2016 · filed 3 January 2017
- was granted 485 shares of HologicSEC Form 416 December 2016Common Stock · traded 14 December 2016 · filed 16 December 2016
- was granted 1,500 shares of Hologic (a derivative holding)SEC Form 416 December 2016Non-qualified Stock Option (Right to Buy) · traded 14 December 2016 · filed 16 December 2016
- ▲ bought on the open market 13,333 shares of AxoGenSEC Form 414 October 2016Common Stock · traded 7 October 2016 · filed 14 October 2016
- was granted 25,000 shares of AxoGen (a derivative holding)SEC Form 413 October 2016Stock Option (right to purchase) · traded 16 September 2016 · filed 13 October 2016
- was granted 3,750 shares of AxoGen (a derivative holding)SEC Form 413 October 2016Stock Option (right to purchase) · traded 16 September 2016 · filed 13 October 2016
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.